首页 / 院系成果 / 成果详情页

Exercise as a platform for pharmacotherapy development in cardiac diseases 期刊论文

编号：

052d2673-a73c-4712-8422-ccb63f656b9b
作者：

Bei, Yihua[0]^[1] Zhou, Qiulian[1]^[1] Sun, Qi[2]^[2] Xiao, Junjie[3]^[3]
地址：

[1]Shanghai University, Regeneration and Ageing Lab,Shanghai,China
[2]Peking Union Medical College, Department of Endocrinology,Beijing,China
[3]Fudan University School of Life Sciences, Regeneration and Ageing Lab,Shanghai,China
语种：

英文
期刊：

Current Pharmaceutical Design ISSN：1381-6128 2015 年 21 卷 30 期 (4409 - 4416)
收录：
关键词：

Aging Cardiac growth Exercise Metabolism MicroRNA Regeneration
摘要：

Moderate exercise is an effective and economic way to prevent and treat cardiovascular diseases. Unlike pathological cardiac growth, exercise-induced cardiac growth, excluding extreme strenuous exercise, does not cause cardiac cell death, fibrosis, and cardiac dysfunction. The balanced cardiomyogenesis (cardiomyocyte hypertrophy and hyperplasia) and neo-angiogenesis are essential determinants for exercise-induced cardiac growth. In particular, exercise leads to physiological cardiac growth through regulating the IGF-1-PI3K-Akt, nitric oxide (NO), C/EBP[1], and PGC-1 © 2015 Bentham Science Publishers.
推荐引用方式
GB/T 7714：

Bei Yihua/56158037500[0],Zhou Qiulian/56037166400[1],Sun Qi/55245866000[2], et al. Exercise as a platform for pharmacotherapy development in cardiac diseases [J].Current Pharmaceutical Design,2015,21(30):4409-4416.
APA：

Bei Yihua/56158037500[0],Zhou Qiulian/56037166400[1],Sun Qi/55245866000[2],Xiao Junjie/35278982600[3].(2015).Exercise as a platform for pharmacotherapy development in cardiac diseases .Current Pharmaceutical Design,21(30):4409-4416.
MLA：

Bei Yihua/56158037500[0], et al. "Exercise as a platform for pharmacotherapy development in cardiac diseases" .Current Pharmaceutical Design 21,30(2015):4409-4416.

浏览次数：10  下载次数：0

分享到：

浏览次数：10

下载次数：0

打印次数：0